Impact of AKI on Urinary Protein Excretion: Analysis of Two Prospective Cohorts
Chi-Yuan Hsu,Raymond K Hsu,Kathleen D Liu,Jingrong Yang,Amanda Anderson,Jing Chen,Vernon M Chinchilli,Harold I Feldman,Amit X Garg,Lee Hamm,Jonathan Himmelfarb,James S Kaufman,John W Kusek,Chirag R Parikh,Ana C Ricardo,Sylvia E Rosas,Georges Saab,Daohang Sha,Edward D Siew,James Sondheimer,Jonathan J Taliercio,Wei Yang,Alan S Go,Chronic Renal Insufficiency Cohort (CRIC) Study Investigators and the Assessment, Serial Evaluation, and Subsequent Sequelae of Acute Kidney Injury (ASSESS-AKI) Study,Lawrence J Appel,Jiang He,James P Lash,Panduranga S Rao,Mahboob Rahman,Raymond R Townsend,James Kaufman,Nasrollah Ghahramani,W Brian Reeves,Lan Kong,Ming Wang,Elana Farace,Alan Go,Raymond Hsu,Thida Tan,Juan D Ordonez,Sijie Zheng,T Alp Ikizler,Julia B Lewis,Lorraine Ware,Chirag Parikh,Steven Coca,Dennis G Moledina,Amit Garg,Prasad Devarajan,Michael Zappitelli,Mark Wurfel,Paul L Kimmel,Marva Moxey Mims
DOI: https://doi.org/10.1681/ASN.2018101036
Abstract:Background: Prior studies of adverse renal consequences of AKI have almost exclusively focused on eGFR changes. Less is known about potential effects of AKI on proteinuria, although proteinuria is perhaps the strongest risk factor for future loss of renal function. Methods: We studied enrollees from the Assessment, Serial Evaluation, and Subsequent Sequelae of AKI (ASSESS-AKI) study and the subset of the Chronic Renal Insufficiency Cohort (CRIC) study enrollees recruited from Kaiser Permanente Northern California. Both prospective cohort studies included annual ascertainment of urine protein-to-creatinine ratio, eGFR, BP, and medication use. For hospitalized participants, we used inpatient serum creatinine measurements obtained as part of clinical care to define an episode of AKI (i.e., peak/nadir inpatient serum creatinine ≥1.5). We performed mixed effects regression to examine change in log-transformed urine protein-to-creatinine ratio after AKI, controlling for time-updated covariates. Results: At cohort entry, median eGFR was 62.9 ml/min per 1.73 m2 (interquartile range [IQR], 46.9-84.6) among 2048 eligible participants, and median urine protein-to-creatinine ratio was 0.12 g/g (IQR, 0.07-0.25). After enrollment, 324 participants experienced at least one episode of hospitalized AKI during 9271 person-years of follow-up; 50.3% of first AKI episodes were Kidney Disease Improving Global Outcomes stage 1 in severity, 23.8% were stage 2, and 25.9% were stage 3. In multivariable analysis, an episode of hospitalized AKI was independently associated with a 9% increase in the urine protein-to-creatinine ratio. Conclusions: Our analysis of data from two prospective cohort studies found that hospitalization for an AKI episode was independently associated with subsequent worsening of proteinuria.